Jumpspeed Ventures
VC Fund
Jerusalem, Israel
Jumpspeed Ventures is a Micro-Fund based in Jerusalem, the Capital of the Startup Nation. Jumpspeed invests in early-stage (pre-seed and seed) software startups that originate in Jerusalem's startup eco-system. Jumpspeed is managed by Ben Wiener.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Jumpspeed Ventures invests in
Stages Jumpspeed Ventures invests in
Countries Jumpspeed Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $1.5M–$14M
- Series A
- $10M–$20M
Investment Focus
Industry
- Artificial Intelligence 5 (31%)
- Software 4 (25%)
- Big Data 2 (13%)
- Health Care 2 (13%)
- Machine Learning 2 (13%)
Stage
- Seed 8 (50%)
- Pre-Seed 4 (25%)
- Series A 2 (13%)
- Series C 1 (6%)
- Funding Round 1 (6%)
Country
- Israel 8 (50%)
- United States 3 (19%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ben Wiener
Managing Partner
|
Managing Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tenna Systems
|
Tenna Systems develops a platform that supports real-time monitoring, geolocation, and mitigation of radio-frequency interference to help maintain dependable connectivity for mission-critical systems. Its technology is informed by extensive experience in electromagnetic warfare and is designed to enhance awareness of RF activity across complexoperational environments. Tip&Cue supports defense, aerospace, and mobility organizations by enabling detection and analysis of interference sources and by strengthening the resilience of systems that depend on spectrum availability. | $13.5M / Seed / Feb 08, 2026 | |
NeuroKaire
|
NeuoKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing. | $10M / Dec 17, 2024 | |
Lidwave
|
Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations. | $10M / Seed / Oct 14, 2024 | |
MDI Health
|
MDI Health offers an AI-powered platform that provides unique decision support tools for personalized drug treatments. It uses its patent-pending technology, methodology, and algorithms to ensure early detection of potential Medication-Related Problems (MRPs) during the course of the drug treatment and to ensure the optimal balance between efficacyand safety of the treatment. | $20M / Series A / Feb 13, 2023 | |
Ginzi
|
Ginzi is an AI support tool designed to help agents improve performance by providing fast and accurate responses. Its AI learns from past interactions, allowing it to generate relevant answers, significantly reducing the time needed to resolve customer queries. This results in a much faster response rate compared to traditional methods. | $1.5M / Seed / Dec 01, 2022 | |
|
NeuroKaire
|
NeuoKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing. | $10M / Series A / Sep 30, 2021 | |
Urbanico
|
Urbanico is building an urban intelligence platform, providing hyper localized risk analysis of the urban landscape. | $1.5M / Seed / Jul 01, 2021 | |
|
MDI Health
|
MDI Health offers an AI-powered platform that provides unique decision support tools for personalized drug treatments. It uses its patent-pending technology, methodology, and algorithms to ensure early detection of potential Medication-Related Problems (MRPs) during the course of the drug treatment and to ensure the optimal balance between efficacyand safety of the treatment. | $6M / Seed / Jun 29, 2021 | |
BreezoMeter
|
BreezoMeter is the provider of street-level and real-time air quality information; their suite of easy-to-integrate APIs includes air pollution, pollen, and active fire data.Product and healthcare brands, such as Siemens, Tata Motors, and allergy pharmaceutical provider ALK, choose to integrate BreezoMeter thanks to their unmatched level ofreal-time accuracy. BreezoMeter is the only AQ provider with a published accuracy validation process.BreezoMeter's exceptional team of multi-disciplinary scientists and engineers has managed to achieve this unparalleled accuracy thanks to a unique multi-data layer approach to air quality based on information from governmental sensors, satellites, weather, traffic, and more.The company then deploys hundreds of air quality calculations at once, using sophisticated modeling and AI, in order to calculate air quality up to a resolution of 0.003 miles (5 meters/16 feet) in 90+ countries on an hourly basis. | $30M / Series C / Jun 28, 2021 | |
Wisio
|
Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable. | $1.6M / Seed / Jun 21, 2021 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Jumpspeed Ventures invest in?
Jumpspeed Ventures invests primarily in Artificial Intelligence, Software and Big Data startups, most often at Seed and Pre-Seed stage. Most of the 16 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jumpspeed Ventures's check size?
Jumpspeed Ventures typically joins rounds of $1.5M–$14M at Seed and $10M–$20M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jumpspeed Ventures participates in.
How do I contact Jumpspeed Ventures?
Public channels for Jumpspeed Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Jumpspeed Ventures?
The team at Jumpspeed Ventures includes Ben Wiener (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
